A mixed performance in the stock price over the year has left investors with either an optimistic or pessimistic outlook, depending on their point of view. The metric has seen a significant gain of 1.49% since the start of this calendar year. Looking back over the last six months, we can see a stronger performance of -16.65%. Over the past 30 days, the price of FOLD has fallen by 1.59%. And in the last five days, it has fallen by -0.10%.
Amicus Therapeutics Inc ‘s stock market performance has been somewhat erratic. The company’s stock reached a 1-year high price of $14.02 on 02/27/24, while the lowest value for the same period was recorded at $8.78 on 01/13/25.
52-week price history of FOLD Stock
Analyzing a stock’s 52-week high and low prices can offer important information about its present condition and future outlook. Amicus Therapeutics Inc’s current trading price is -31.81% away from its 52-week high, while its distance from the 52-week low is 8.82%. The stock’s price range during this period has varied between$8.78 and $14.02. The Amicus Therapeutics Inc’s shares, which operate in the Healthcare, saw a trading volume of around 4.44 million for the day, a figure considerably higher than their average daily volume of 2.29 million over last three months.
Market Capitalization vs. Financial Performance: A Comparative Study
Amicus Therapeutics Inc (FOLD) has experienced a quarterly decline of -5.25% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 2.86B and boasts a workforce of 517 employees.
Combining Moving Average and Trading Volume Data for Better Market Insight
Based on Barchart.com data, the company’s moving average over the 100-day period was 10.13, with a change in price of -1.66. Similarly, Amicus Therapeutics Inc recorded 2,407,100 in trading volume during the last 100 days, posting a change of -14.80%.
FOLD’s Debt-to-Equity Ratio Cause for Concern? An In-Depth Look
The debt-to-equity (D/E) ratio is a significant metric that provides insights into a company’s financial state and market presence. By dividing a company’s current liabilities by its shareholders’ equity, the D/E ratio depicts the extent of debt used by a company to fund its assets relative to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for FOLD stands at 2.49. Similarly, the long-term debt-to-equity ratio is also 2.44.
FOLD Stock Stochastic Average
Amicus Therapeutics Inc’s raw stochastic average for the past 50 days is presently 49.36%, as of today. This marks a decrease from the raw stochastic average of the last 20 days, which was 52.68%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 70.87% and 73.20%, respectively.
